Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;22(6):1340-1341.
doi: 10.1016/j.cgh.2023.10.032. Epub 2023 Nov 17.

Reply

Amit G Singal  1 , Darine Daher  1 , Karim Seif El Dahan  1 , Nicole E Rich  1 , Ju Dong Yang  2 , Neehar D Parikh  3
Affiliations

Reply

Amit G Singal et al. Clin Gastroenterol Hepatol. 2024 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

Amit Singal has served as a consultant or on advisory boards for Genentech, AztraZeneca, Eisai, Exelixis, Bayer, FujiFilm Medical Sciences, Exact Sciences, Roche, Glycotest, Freenome, and GRAIL.

Ju Dong Yang provides a consulting service for AstraZeneca, Eisai, Exact Sciences, FujiFilm Medical Sciences, and Gilead Sciences.

Nicole Rich has served as a consultant for AstraZeneca

Neehar Parikh has served as a consultant or advisory boards for Eisai, Exelixis, Fujifilm Medical Sciences, and Gilead.

None of the other authors have any relevant conflicts of interest to disclose.

References

    1. Daher D, Seif El Dahan K, Cano A, et al. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients with Cirrhosis. Clin Gastroenterol Hepatol 2023. - PMC - PubMed
    1. Poustchi H, Farrell GC, Strasser SI, et al. Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology 2011;54:1998–2004. - PubMed
    1. Singal AG, Tiro JA, Murphy CC, et al. Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol 2021;19:987–995 e1. - PMC - PubMed
    1. Simmons OL, Feng Y, Parikh ND, et al. Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance. Clin Gastroenterol Hepatol 2019;17:766–773. - PMC - PubMed
    1. Singal AG, Zhang E, Narasimman M, et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis. J Hepatol 2022;77:128–139. - PMC - PubMed